Progressive supranuclear palsy is a rare condition that affects the brain. The condition is also called Steele-Richardson-Olszewski syndrome. Progressive supranuclear palsy causes the brain cells that ...

The Rev. Jesse Jackson listens to speakers at the Tabernacle Baptist Church during the 60th anniversary of the march to ensure that African Americans could exercise their constitutional right to vote, ...

QUARANTINE RIGHT NOW. CIVIL RIGHTS LEADER IN GREENVILLE NATIVE JESSE JACKSON’S UPDATED HEALTH DIAGNOSIS OF PROGRESSIVE SUPRANUCLEAR PALSY HAS RAISED MANY QUESTIONS ABOUT WHAT THIS DISEASE MEANS FOR ...

The civil rights leader's organization, the Rainbow PUSH Coalition, announced on Wednesday that Jackson had been hospitalized Scott Olson/Getty Rev. Jesse Jackson has reportedly been hospitalized and ...

A clinical trial that will test three drugs concurrently, and could include more, represents new hope for patients with progressive supranuclear palsy (PSP), an incurable neurodegenerative disorder ...

After 48 weeks of treatment, TPN-101 reduced the levels of neurofilament light chain and interleukin 6, both key biomarkers of neurodegeneration and neuroinflammation in PSP. The Food and Drug ...

BARCELONA, Spain--(BUSINESS WIRE)--Ferrer, a B Corp-certified international pharmaceutical company, has announced the dosing of the first participant in the Phase II clinical trial, PROSPER. The study ...

Preclinical mouse models show FNP-223 reduces tau pathology. The Food and Drug Administration (FDA) has received Fast Track designation for FNP-223 for the treatment of progressive supranuclear palsy ...

This is a randomized, double-blind, placebo-controlled Phase II clinical trial designed to evaluate the efficacy, safety, and pharmacokinetics of FNP-223 (oral formulation) in slowing the progression ...